Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.
University of Queensland Diamantina Institute – $100,000 USD / $136,000 AUD (Approx)
$100,000.00 USD
September 2021
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Duke University Hospital – $50,000
$50,000.00 USD
September 2021
Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors
Funding of PBTCF 2021: PBTC-059 - $25,000
$25,000.00 USD
January 2021
Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma
International DIPG/DMG Registry And Repository - $1,508,198
$1,508,198.00 USD
December 2020
Children's Cancer Institute - $99,251 USD / $140,212 AUD (Approx)
$99,251.00 USD
September 2020
Discovering New Epigenetic Players in DIPG Oncogenesis
Northwestern Memorial Hospital - $110,000
$110,000.00 USD
September 2020
Development of Histone Demethylase Inhibitor Against DIPG
The Hospital for Sick Children - $100,000
$100,000.00 USD
September 2020
Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma
Hunter Medical Research Institute - $145,640 USD / $199,527 AUD (Approx)
$145,640.00 USD
September 2020
Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas
CONNECT Consortium - $489,801.26
$489,801.00 USD
September 2020
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
International DIPG/DMG Registry And Repository - $862,671
$862,671.00 USD
May 2020
Funding of PBTCF 2020: PBTC-058 - $25,000
$25,000.00 USD
January 2020
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
Sydney Children's Hospital - $151,468 USD / $219,386 AUD (Approx)
$151,468.00 USD
December 2019
Developing New Epigenetic Combination Treatments Against DIPG.
Oncoceutics ONC201 - $100,000
$100,000.00 USD
December 2019
Expansion of the ONC201 Compassionate Use.
University of Sydney - $100,000 USD / $146,520 AUD (Approx)
$100,000.00 USD
November 2019
Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.
University of Michigan Hospitals - $157,856
$157,856.00 USD
November 2019
Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG